Predicting mortality and treatment-related adverse events in older patients undergoing surgical treatment for head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge.
We evaluated the utility of the Geriatric-8 (G8), a geriatric screening tool, in predicting delirium, postoperative complications, and prognosis.
